feed,title,long_url,short_url
SeekingAlpha,"EVI GAAP EPS of $0.14, revenue of $90.15M",https://seekingalpha.com/news/4149291,
SeekingAlpha,Neurocrine ending development of luvadaxistat amid failed study,https://seekingalpha.com/news/4149290,
SeekingAlpha,180 Life Sciences appoints Omar Jimenez as CFO,https://seekingalpha.com/news/4149289,
